Sirona Biochem (CVE:SBM) Stock Price Down 16.7% – What’s Next?

Sirona Biochem Corp. (CVE:SBM) shares traded down 16.7% during trading on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. 113,000 shares traded hands during mid-day trading, an increase of 91% from the average session volume of 59,069 shares. The stock had previously closed at C$0.06.

Sirona Biochem Stock Performance

The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The firm has a market capitalization of C$12.84 million, a PE ratio of -5.00 and a beta of -0.03. The firm’s 50-day moving average price is C$0.06 and its two-hundred day moving average price is C$0.06.

About Sirona Biochem

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.